ALTO - MOMO ALTO and SLI among pre market gainers

Biodesix (BDSX) +53%. Actinium Pharmaceuticals ATNM +44% on agreement with Immedica Pharma for conditioning agent. BioCardia BCDA +34% after FDA nod to begin trial of BCDA-04 in COVID patients. Aeglea BioTherapeutics AGLE +19% on filing seeking FDA approval of pegzilarginase for rare disorder. Cyclacel Pharmaceuticals (CYCC) +16% announces publication confirming fadraciclib suppresses MCL1 and synergizes with venetoclax in chronic lymphocytic leukemia. MIND Technology MIND +14% on ~$7.3M orders. RLX Technology (RLX) +12%. Indonesia Energy Corporation (INDO) +9%. Veru VERU +8% after closing Monday up 182% due to COVID candidate data. AgEagle Aerial Systems UAVS +8% on FY results. OrganiGram Holdings OGI +9% on Q2 results. Imperial Petroleum (IMPP) +7%. Standard Lithium (SLI) +7%. ERYTECH Pharma (ERYP) +7%. Lion Group Holding (LGHL) +6%. Huazhu Group (HTHT) +6%. Hello Group (MOMO) +6%. Houston American Energy (HUSA) +5%. Alto Ingredients (ALTO) +6%.

For further details see:

MOMO, ALTO and SLI among pre market gainers